Invention Grant
- Patent Title: 1,4-disubstituted pyridazine quinolne analogs there of and methods for treating SMN-deficiency-related conditions
-
Application No.: US16259441Application Date: 2019-01-28
-
Publication No.: US11672799B2Publication Date: 2023-06-13
- Inventor: Atwood Kim Cheung , Natalie Dales , Timothy Brian Hurley
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Adil R. Zhugralin
- Main IPC: A61K31/501
- IPC: A61K31/501 ; C07D401/14 ; C07D401/04 ; A61K31/502 ; A61K31/517 ; C07D487/10 ; C07D405/14 ; C07D413/14 ; C07D487/04 ; A61K31/5377
Abstract:
The present invention provides a compound of formula IA or a pharmaceutically acceptable salt thereof;
a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Public/Granted literature
Information query
IPC分类:
